{"id":1239309,"title":"DSEN Abstract: Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T19:21:15.915000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53213.html?wbdisable=true","snippet":"DSEN Abstract Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure Despite low rates of sofosbuvir failure in the pivotal clinical trials (2 - 4%), this real-world trial shows a higher failure rate of 9.5%. This study also found that patients…","rawSnapshotUrl":"/api/snapshots/raw/1239309","browseUrl":"https://replay.healtharchive.ca/job-8/20260306192115/https://cihr-irsc.gc.ca/e/53213.html?wbdisable=true#ha_snapshot=1239309","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}